Dow Down 0.02% Nasdaq Up 0.07%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
138.65 1.64(1.17%) Nov 25, 4:00PM EST
Prev Close:140.29
Open:140.29
Bid:50.00 x 100
Ask:143.23 x 400
1y Target Est:161.11
Beta:1.36
Next Earnings Date:N/A
Day's Range:136.40 - 141.94
52wk Range:82.51 - 154.89
Volume:586,440
Avg Vol (3m):791,995
Market Cap:10.47B
P/E (ttm):124.91
EPS (ttm):1.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PCYC

Comparison

Symbol% ChgMkt Cap
PCYCDown 1.17%10.47B
CTIC325.11M
MRK169.17B

Key Statistics

Forward P/E (1 yr):495.18
P/S (ttm):18.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.85
Quarterly EPS Est (Dec-14) :0.58
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1,019.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback